- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00893698
Bilateral Allotransplantation of Upper Limbs
August 28, 2014 updated by: Assistance Publique Hopitaux De Marseille
The aim of the study is to realize a bilateral transplantation of upper limbs.
The first objective is functional but there are aesthetic and psychologic imperatives too.
This open and descriptive study needs compatible donor and recipient.
The sample should be realized simultaneously and the transplantation should be made by two coordinated teams according to this sequence : osteosynthesis, vascular anastomosis, sutures of tendons and nervous sutures.
An immunosuppressant treatment should be initialized from the beginning of the intervention and continued for life.
Rejections should be screened by regular clinical and histological examinations.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
5
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Marseille, France, 13354
- Recruiting
- Assistance Publique Hôpitaux de Marseille
-
Contact:
- guy MAGALON
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 50 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
Donor:
- State of brain death
- Compatibility with recipient about sex, size, age and color
- Blood compatibility; integrity of upper limbs
Recipient:
- Double amputation of hands or forearms with traumatic origin
- Personal motivation
- Good health condition
- Delay from 2 months to 34 years between amputation and transplantation
Exclusion Criteria:
Donor:
- Uncompatibility with sample
- Lesion on upper limbs
- Neoplasia
- Hepatitis B or C
- Positive CMV serology
Recipient:
- Uncompatibility with immunosuppressant treatment
- Psychosis
- Carcinosis
- Cardiovascular diseases
- Addiction to alcohol or smoking
- Pregnancy
- Feeding
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Functional rehabilitation of patients by bilateral allotransplantation of upper limbs, evaluated by measure of the function of the transplanted extremities
Time Frame: 6 years
|
6 years
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Aesthetic and psychologic
Time Frame: 6 years
|
6 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2009
Primary Completion (Anticipated)
January 1, 2015
Study Registration Dates
First Submitted
May 5, 2009
First Submitted That Met QC Criteria
May 5, 2009
First Posted (Estimate)
May 6, 2009
Study Record Updates
Last Update Posted (Estimate)
August 29, 2014
Last Update Submitted That Met QC Criteria
August 28, 2014
Last Verified
August 1, 2014
More Information
Terms related to this study
Other Study ID Numbers
- 2008/17
- 2008-A00516-49
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.